| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 148 | 2024 | 3627 | 10.460 |
Why?
|
| Heart Defects, Congenital | 106 | 2024 | 4673 | 6.250 |
Why?
|
| Hypoplastic Left Heart Syndrome | 37 | 2023 | 594 | 4.550 |
Why?
|
| Fontan Procedure | 41 | 2024 | 796 | 4.390 |
Why?
|
| Heart Ventricles | 65 | 2023 | 3813 | 4.050 |
Why?
|
| Transposition of Great Vessels | 31 | 2023 | 580 | 4.050 |
Why?
|
| Tricuspid Valve Insufficiency | 15 | 2023 | 353 | 3.900 |
Why?
|
| Mitral Valve | 35 | 2023 | 1465 | 3.350 |
Why?
|
| Aortic Valve Insufficiency | 23 | 2023 | 576 | 3.300 |
Why?
|
| Pulmonary Valve | 21 | 2024 | 411 | 3.270 |
Why?
|
| Heart Valve Prosthesis | 22 | 2022 | 1463 | 2.960 |
Why?
|
| Myocardial Reperfusion Injury | 26 | 2022 | 480 | 2.940 |
Why?
|
| Heart Valve Prosthesis Implantation | 29 | 2022 | 1555 | 2.800 |
Why?
|
| Aortic Valve | 30 | 2022 | 1959 | 2.800 |
Why?
|
| Tetralogy of Fallot | 30 | 2024 | 618 | 2.750 |
Why?
|
| Heart Septal Defects, Ventricular | 26 | 2023 | 477 | 2.640 |
Why?
|
| Heart Septal Defects, Atrial | 20 | 2023 | 451 | 2.360 |
Why?
|
| Heart Valve Diseases | 13 | 2023 | 1031 | 2.340 |
Why?
|
| Models, Cardiovascular | 20 | 2024 | 983 | 2.320 |
Why?
|
| Heart Septal Defects | 11 | 2024 | 190 | 2.280 |
Why?
|
| Mitral Valve Insufficiency | 21 | 2023 | 1400 | 2.250 |
Why?
|
| Echocardiography, Three-Dimensional | 26 | 2017 | 607 | 2.130 |
Why?
|
| Myocardium | 59 | 2023 | 4746 | 2.100 |
Why?
|
| Myocardial Contraction | 39 | 2018 | 1516 | 2.000 |
Why?
|
| Myocardial Ischemia | 24 | 2023 | 2133 | 1.900 |
Why?
|
| Tricuspid Valve | 16 | 2023 | 410 | 1.840 |
Why?
|
| Ventricular Outflow Obstruction | 15 | 2021 | 261 | 1.760 |
Why?
|
| Ebstein Anomaly | 7 | 2024 | 105 | 1.740 |
Why?
|
| Thoracic Surgery | 10 | 2024 | 722 | 1.700 |
Why?
|
| Infant | 191 | 2024 | 36169 | 1.640 |
Why?
|
| Endocardial Fibroelastosis | 9 | 2021 | 56 | 1.620 |
Why?
|
| Heart Valves | 9 | 2023 | 284 | 1.580 |
Why?
|
| Hemodynamics | 47 | 2024 | 4165 | 1.540 |
Why?
|
| Robotics | 15 | 2021 | 817 | 1.530 |
Why?
|
| Reoperation | 58 | 2024 | 4303 | 1.510 |
Why?
|
| Ventricular Function, Right | 14 | 2021 | 618 | 1.500 |
Why?
|
| Pulmonary Artery | 37 | 2024 | 1929 | 1.480 |
Why?
|
| Child, Preschool | 158 | 2024 | 42224 | 1.430 |
Why?
|
| Cardiomegaly | 14 | 2022 | 590 | 1.430 |
Why?
|
| Hypertrophy, Left Ventricular | 14 | 2017 | 854 | 1.380 |
Why?
|
| Heart Neoplasms | 7 | 2021 | 364 | 1.370 |
Why?
|
| Norwood Procedures | 8 | 2023 | 192 | 1.370 |
Why?
|
| Infant, Newborn | 129 | 2024 | 26199 | 1.360 |
Why?
|
| Cardiopulmonary Bypass | 28 | 2020 | 1092 | 1.360 |
Why?
|
| Swine | 51 | 2023 | 5909 | 1.350 |
Why?
|
| Postoperative Complications | 65 | 2024 | 15637 | 1.340 |
Why?
|
| Cardioplegic Solutions | 11 | 2012 | 123 | 1.330 |
Why?
|
| Rabbits | 56 | 2023 | 4750 | 1.270 |
Why?
|
| Child | 165 | 2024 | 80152 | 1.250 |
Why?
|
| Pericardium | 11 | 2023 | 674 | 1.250 |
Why?
|
| Treatment Outcome | 156 | 2024 | 64681 | 1.220 |
Why?
|
| Heart Arrest, Induced | 13 | 2012 | 358 | 1.210 |
Why?
|
| Mitral Valve Stenosis | 10 | 2023 | 341 | 1.200 |
Why?
|
| Abnormalities, Multiple | 19 | 2017 | 1423 | 1.200 |
Why?
|
| Cardiac Output, Low | 8 | 2016 | 191 | 1.180 |
Why?
|
| Surgery, Computer-Assisted | 14 | 2012 | 1003 | 1.170 |
Why?
|
| Ventricular Dysfunction, Right | 11 | 2018 | 629 | 1.110 |
Why?
|
| Mitral Valve Annuloplasty | 4 | 2018 | 144 | 1.110 |
Why?
|
| Mitochondria | 13 | 2023 | 3620 | 1.070 |
Why?
|
| Aorta, Thoracic | 17 | 2023 | 1096 | 1.070 |
Why?
|
| Prosthesis Design | 17 | 2022 | 2114 | 1.030 |
Why?
|
| Reperfusion Injury | 8 | 2023 | 1026 | 1.030 |
Why?
|
| Heart Transplantation | 26 | 2023 | 3258 | 1.010 |
Why?
|
| Bioprosthesis | 8 | 2022 | 591 | 0.990 |
Why?
|
| Ventricular Function, Left | 25 | 2021 | 3899 | 0.980 |
Why?
|
| Retrospective Studies | 164 | 2024 | 80674 | 0.960 |
Why?
|
| Atrioventricular Block | 2 | 2024 | 133 | 0.960 |
Why?
|
| Coronary Vessel Anomalies | 7 | 2023 | 307 | 0.950 |
Why?
|
| Calcium | 22 | 2020 | 5719 | 0.940 |
Why?
|
| Fibroma | 4 | 2021 | 190 | 0.920 |
Why?
|
| Ventricular Dysfunction, Left | 14 | 2021 | 2131 | 0.910 |
Why?
|
| Heart Bypass, Right | 7 | 2014 | 75 | 0.910 |
Why?
|
| Cardiovascular Surgical Procedures | 11 | 2021 | 190 | 0.900 |
Why?
|
| Humans | 394 | 2024 | 761208 | 0.890 |
Why?
|
| Cardiac Valve Annuloplasty | 3 | 2020 | 51 | 0.880 |
Why?
|
| Myocardial Reperfusion | 12 | 2004 | 339 | 0.870 |
Why?
|
| Echocardiography | 39 | 2022 | 5006 | 0.870 |
Why?
|
| Stress, Mechanical | 11 | 2019 | 1674 | 0.830 |
Why?
|
| Protein Kinase C | 8 | 2004 | 1202 | 0.830 |
Why?
|
| Pulmonary Valve Insufficiency | 7 | 2020 | 140 | 0.830 |
Why?
|
| Endocardial Cushion Defects | 4 | 2013 | 43 | 0.810 |
Why?
|
| Palliative Care | 24 | 2023 | 3599 | 0.800 |
Why?
|
| Time Factors | 82 | 2024 | 39957 | 0.800 |
Why?
|
| Arteriovenous Malformations | 4 | 2012 | 396 | 0.800 |
Why?
|
| Animals | 171 | 2023 | 168079 | 0.770 |
Why?
|
| Mitral Valve Prolapse | 2 | 2021 | 212 | 0.760 |
Why?
|
| Ventricular Function | 7 | 2020 | 406 | 0.760 |
Why?
|
| Double Outlet Right Ventricle | 7 | 2022 | 60 | 0.750 |
Why?
|
| Extracorporeal Membrane Oxygenation | 20 | 2024 | 1462 | 0.730 |
Why?
|
| Mitochondria, Muscle | 5 | 2020 | 172 | 0.730 |
Why?
|
| Aortic Coarctation | 9 | 2011 | 275 | 0.720 |
Why?
|
| Aortic Valve Stenosis | 13 | 2023 | 2018 | 0.700 |
Why?
|
| Histidine | 7 | 1999 | 303 | 0.680 |
Why?
|
| Disease Models, Animal | 39 | 2021 | 18220 | 0.680 |
Why?
|
| Heart Septum | 8 | 2009 | 301 | 0.680 |
Why?
|
| Clinical Competence | 9 | 2016 | 4788 | 0.680 |
Why?
|
| Heart | 31 | 2023 | 4431 | 0.670 |
Why?
|
| Biomedical Engineering | 1 | 2020 | 286 | 0.640 |
Why?
|
| Computer Simulation | 10 | 2018 | 6224 | 0.640 |
Why?
|
| Cardiotonic Agents | 7 | 2016 | 540 | 0.640 |
Why?
|
| Pacemaker, Artificial | 3 | 2023 | 807 | 0.640 |
Why?
|
| Truncus Arteriosus, Persistent | 6 | 2023 | 63 | 0.620 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2017 | 1086 | 0.610 |
Why?
|
| Oxygenators | 1 | 2018 | 36 | 0.610 |
Why?
|
| Heart-Lung Machine | 1 | 2018 | 44 | 0.610 |
Why?
|
| Adolescent | 100 | 2024 | 88298 | 0.610 |
Why?
|
| Male | 207 | 2024 | 360693 | 0.610 |
Why?
|
| Pulmonary Veins | 7 | 2022 | 743 | 0.590 |
Why?
|
| Jugular Veins | 2 | 2016 | 210 | 0.580 |
Why?
|
| Monosaccharide Transport Proteins | 5 | 2005 | 436 | 0.580 |
Why?
|
| Quality Indicators, Health Care | 5 | 2014 | 1789 | 0.580 |
Why?
|
| Coronary Circulation | 14 | 2019 | 1611 | 0.570 |
Why?
|
| Length of Stay | 19 | 2022 | 6417 | 0.570 |
Why?
|
| Female | 208 | 2024 | 392544 | 0.570 |
Why?
|
| Water Microbiology | 1 | 2018 | 113 | 0.570 |
Why?
|
| Heating | 1 | 2018 | 104 | 0.570 |
Why?
|
| Pulmonary Atresia | 11 | 2023 | 159 | 0.560 |
Why?
|
| Monitoring, Intraoperative | 4 | 2018 | 944 | 0.560 |
Why?
|
| Mitochondria, Heart | 5 | 2022 | 229 | 0.550 |
Why?
|
| Myocytes, Cardiac | 10 | 2021 | 1666 | 0.550 |
Why?
|
| Water Supply | 1 | 2018 | 204 | 0.540 |
Why?
|
| Venous Valves | 1 | 2016 | 14 | 0.540 |
Why?
|
| Equipment Contamination | 1 | 2018 | 182 | 0.540 |
Why?
|
| Thoracic Surgical Procedures | 3 | 2016 | 350 | 0.540 |
Why?
|
| Organ Preservation | 5 | 2018 | 382 | 0.540 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 128 | 0.530 |
Why?
|
| Aortic Stenosis, Supravalvular | 3 | 2019 | 28 | 0.530 |
Why?
|
| Aorta | 12 | 2023 | 2040 | 0.530 |
Why?
|
| Models, Anatomic | 5 | 2016 | 683 | 0.530 |
Why?
|
| Aftercare | 10 | 2023 | 913 | 0.530 |
Why?
|
| Endocardium | 6 | 2022 | 248 | 0.520 |
Why?
|
| Follow-Up Studies | 63 | 2023 | 39126 | 0.520 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 86 | 0.510 |
Why?
|
| Ultrasonography, Interventional | 8 | 2010 | 1496 | 0.510 |
Why?
|
| Suture Techniques | 6 | 2012 | 768 | 0.500 |
Why?
|
| Risk Assessment | 33 | 2024 | 24021 | 0.500 |
Why?
|
| Apoptosis | 9 | 2023 | 9477 | 0.500 |
Why?
|
| Transplantation | 1 | 2017 | 221 | 0.500 |
Why?
|
| Philosophy, Medical | 1 | 2015 | 79 | 0.490 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2012 | 60 | 0.490 |
Why?
|
| Ventricular Remodeling | 6 | 2020 | 1270 | 0.480 |
Why?
|
| Stroke Volume | 17 | 2021 | 5521 | 0.480 |
Why?
|
| Equipment Design | 16 | 2018 | 3510 | 0.480 |
Why?
|
| Recovery of Function | 15 | 2020 | 2981 | 0.480 |
Why?
|
| Cardiology | 4 | 2016 | 1693 | 0.470 |
Why?
|
| Hospital Mortality | 12 | 2020 | 5295 | 0.470 |
Why?
|
| Heart Diseases | 11 | 2022 | 2795 | 0.470 |
Why?
|
| Papillary Muscles | 4 | 2023 | 192 | 0.460 |
Why?
|
| Pulmonary Valve Stenosis | 5 | 2023 | 164 | 0.460 |
Why?
|
| Patient Discharge | 12 | 2023 | 3441 | 0.450 |
Why?
|
| Dopamine | 4 | 2009 | 1601 | 0.450 |
Why?
|
| Glycolysis | 7 | 2007 | 836 | 0.450 |
Why?
|
| Perfusion | 11 | 2023 | 1390 | 0.450 |
Why?
|
| Intraoperative Care | 5 | 2011 | 767 | 0.440 |
Why?
|
| Risk Factors | 65 | 2024 | 74239 | 0.440 |
Why?
|
| Echocardiography, Doppler, Color | 8 | 2019 | 352 | 0.440 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 2012 | 216 | 0.440 |
Why?
|
| Animals, Newborn | 19 | 2017 | 2665 | 0.440 |
Why?
|
| Aortic Diseases | 3 | 2023 | 735 | 0.430 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2017 | 3493 | 0.430 |
Why?
|
| Catheterization | 10 | 2011 | 1428 | 0.430 |
Why?
|
| Ventricular Pressure | 11 | 2019 | 210 | 0.430 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2005 | 254 | 0.430 |
Why?
|
| Endoscopy | 4 | 2017 | 1852 | 0.430 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 1141 | 0.420 |
Why?
|
| Boston | 21 | 2017 | 9327 | 0.410 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2011 | 4052 | 0.410 |
Why?
|
| Glycoproteins | 1 | 2020 | 2203 | 0.400 |
Why?
|
| Coronary Vessels | 10 | 2016 | 3111 | 0.400 |
Why?
|
| Marketing of Health Services | 1 | 2013 | 150 | 0.400 |
Why?
|
| Tissue Adhesives | 1 | 2014 | 173 | 0.400 |
Why?
|
| Heart Failure | 13 | 2022 | 11701 | 0.390 |
Why?
|
| Carotid Arteries | 2 | 2014 | 941 | 0.390 |
Why?
|
| Collagen | 4 | 2019 | 2635 | 0.390 |
Why?
|
| Cardiac Pacing, Artificial | 8 | 2015 | 866 | 0.390 |
Why?
|
| Age Factors | 22 | 2020 | 18384 | 0.380 |
Why?
|
| Discrete Subaortic Stenosis | 3 | 2020 | 16 | 0.380 |
Why?
|
| Device Approval | 1 | 2013 | 163 | 0.380 |
Why?
|
| Operating Rooms | 1 | 2018 | 790 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2020 | 2247 | 0.380 |
Why?
|
| History, 20th Century | 5 | 2020 | 2765 | 0.380 |
Why?
|
| Prosthesis Failure | 7 | 2022 | 1204 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2018 | 36415 | 0.370 |
Why?
|
| Azygos Vein | 1 | 2010 | 19 | 0.370 |
Why?
|
| Hepatic Veins | 2 | 2010 | 112 | 0.370 |
Why?
|
| Diastole | 9 | 2019 | 782 | 0.360 |
Why?
|
| Transplantation, Heterotopic | 6 | 2023 | 175 | 0.360 |
Why?
|
| Young Adult | 40 | 2024 | 59221 | 0.360 |
Why?
|
| Materials Testing | 6 | 2019 | 865 | 0.360 |
Why?
|
| Endoscopes | 1 | 2011 | 169 | 0.360 |
Why?
|
| Transplantation, Autologous | 8 | 2020 | 2112 | 0.350 |
Why?
|
| Computer-Aided Design | 2 | 2012 | 297 | 0.350 |
Why?
|
| Biocompatible Materials | 4 | 2014 | 1683 | 0.350 |
Why?
|
| Hospitals, Pediatric | 3 | 2016 | 1862 | 0.350 |
Why?
|
| Absorbable Implants | 1 | 2012 | 338 | 0.350 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 373 | 0.340 |
Why?
|
| Ultrasonography | 19 | 2014 | 5969 | 0.340 |
Why?
|
| Thoracic Surgery, Video-Assisted | 4 | 2017 | 285 | 0.340 |
Why?
|
| Survival Rate | 25 | 2019 | 12728 | 0.340 |
Why?
|
| Neovascularization, Physiologic | 5 | 2012 | 1347 | 0.330 |
Why?
|
| Vena Cava, Superior | 7 | 2024 | 196 | 0.330 |
Why?
|
| Chi-Square Distribution | 7 | 2014 | 3418 | 0.330 |
Why?
|
| Vascular Surgical Procedures | 8 | 2022 | 1489 | 0.330 |
Why?
|
| Heart Atria | 9 | 2009 | 1349 | 0.330 |
Why?
|
| Heart Block | 5 | 2022 | 385 | 0.320 |
Why?
|
| Pulmonary Circulation | 9 | 2018 | 737 | 0.320 |
Why?
|
| Dilatation, Pathologic | 8 | 2023 | 527 | 0.320 |
Why?
|
| Tachycardia, Ventricular | 5 | 2022 | 1305 | 0.320 |
Why?
|
| Polyethylene Terephthalates | 3 | 2023 | 112 | 0.320 |
Why?
|
| Cattle | 7 | 2023 | 3818 | 0.310 |
Why?
|
| Cross Infection | 1 | 2018 | 1422 | 0.310 |
Why?
|
| Cytosol | 6 | 2009 | 883 | 0.310 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2381 | 0.310 |
Why?
|
| Postoperative Care | 10 | 2015 | 1468 | 0.310 |
Why?
|
| Sternum | 4 | 2007 | 175 | 0.310 |
Why?
|
| Ventricular Septum | 3 | 2021 | 76 | 0.300 |
Why?
|
| Video Recording | 2 | 2011 | 965 | 0.300 |
Why?
|
| Depth Perception | 1 | 2008 | 94 | 0.300 |
Why?
|
| Contractile Proteins | 2 | 2001 | 240 | 0.290 |
Why?
|
| Biological Products | 1 | 2017 | 915 | 0.290 |
Why?
|
| Thoracoscopy | 2 | 2005 | 183 | 0.290 |
Why?
|
| Fructosediphosphates | 2 | 1998 | 24 | 0.290 |
Why?
|
| Aortic Arch Syndromes | 1 | 2007 | 19 | 0.290 |
Why?
|
| Heart Arrest | 6 | 2022 | 1513 | 0.280 |
Why?
|
| Systole | 6 | 2021 | 936 | 0.280 |
Why?
|
| Fluorescent Dyes | 7 | 2004 | 1901 | 0.280 |
Why?
|
| Sus scrofa | 5 | 2019 | 428 | 0.280 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2012 | 109 | 0.270 |
Why?
|
| Constriction, Pathologic | 9 | 2022 | 1097 | 0.270 |
Why?
|
| Adult | 69 | 2024 | 221119 | 0.270 |
Why?
|
| Lactic Acid | 10 | 2012 | 1139 | 0.270 |
Why?
|
| Heart Aneurysm | 2 | 2007 | 114 | 0.270 |
Why?
|
| Myocardial Stunning | 2 | 2009 | 67 | 0.260 |
Why?
|
| Fetal Heart | 5 | 2015 | 281 | 0.260 |
Why?
|
| Hypothermia, Induced | 7 | 2008 | 754 | 0.260 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 342 | 0.260 |
Why?
|
| Oximes | 1 | 2007 | 303 | 0.260 |
Why?
|
| Lithium Compounds | 1 | 2007 | 223 | 0.250 |
Why?
|
| Survival Analysis | 21 | 2018 | 10088 | 0.250 |
Why?
|
| Arginine | 3 | 2002 | 920 | 0.250 |
Why?
|
| Feasibility Studies | 9 | 2023 | 5250 | 0.250 |
Why?
|
| Nerve Block | 2 | 2024 | 706 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2012 | 8998 | 0.250 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 412 | 0.250 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 1923 | 0.250 |
Why?
|
| Equipment Failure Analysis | 8 | 2013 | 846 | 0.250 |
Why?
|
| Severity of Illness Index | 19 | 2023 | 15841 | 0.250 |
Why?
|
| Rats | 21 | 2023 | 23704 | 0.240 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2012 | 64 | 0.240 |
Why?
|
| Kaplan-Meier Estimate | 16 | 2017 | 6486 | 0.240 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 3 | 2011 | 65 | 0.240 |
Why?
|
| Energy Metabolism | 10 | 2017 | 2877 | 0.240 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1662 | 0.240 |
Why?
|
| Electrocardiography | 6 | 2023 | 6387 | 0.240 |
Why?
|
| Troponin I | 4 | 2016 | 652 | 0.240 |
Why?
|
| Polytetrafluoroethylene | 2 | 2021 | 245 | 0.230 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2008 | 793 | 0.230 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 1288 | 0.230 |
Why?
|
| Diacetyl | 2 | 2009 | 21 | 0.230 |
Why?
|
| Scimitar Syndrome | 2 | 2022 | 30 | 0.230 |
Why?
|
| Tacrolimus | 3 | 2005 | 736 | 0.230 |
Why?
|
| Ischemic Preconditioning | 1 | 2004 | 89 | 0.230 |
Why?
|
| Task Performance and Analysis | 5 | 2014 | 763 | 0.230 |
Why?
|
| Spectrometry, Fluorescence | 4 | 2004 | 683 | 0.230 |
Why?
|
| Multivariate Analysis | 15 | 2016 | 12052 | 0.230 |
Why?
|
| Muscle Proteins | 3 | 2005 | 1149 | 0.230 |
Why?
|
| Research Support as Topic | 1 | 2008 | 697 | 0.220 |
Why?
|
| Glucose-6-Phosphate | 1 | 2003 | 29 | 0.220 |
Why?
|
| Ventricular Dysfunction | 3 | 2017 | 144 | 0.220 |
Why?
|
| Hemodilution | 4 | 2009 | 120 | 0.220 |
Why?
|
| Glucose | 8 | 2005 | 4342 | 0.220 |
Why?
|
| Logistic Models | 13 | 2016 | 13249 | 0.220 |
Why?
|
| Anesthetics, Intravenous | 1 | 2006 | 394 | 0.220 |
Why?
|
| Aneurysm, False | 2 | 2004 | 255 | 0.220 |
Why?
|
| Pressure | 5 | 2014 | 1155 | 0.220 |
Why?
|
| Cold Ischemia | 2 | 2018 | 70 | 0.220 |
Why?
|
| Subclavian Vein | 1 | 2003 | 57 | 0.220 |
Why?
|
| Dilatation | 4 | 2023 | 307 | 0.220 |
Why?
|
| Malus | 1 | 2023 | 50 | 0.210 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 392 | 0.210 |
Why?
|
| Pattern Recognition, Automated | 4 | 2011 | 993 | 0.210 |
Why?
|
| Cyclosporine | 3 | 2005 | 776 | 0.210 |
Why?
|
| Hydrogen-Ion Concentration | 9 | 2003 | 2477 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 8 | 2015 | 3366 | 0.210 |
Why?
|
| Thoracotomy | 3 | 2017 | 366 | 0.210 |
Why?
|
| Video-Assisted Surgery | 1 | 2003 | 51 | 0.210 |
Why?
|
| Amiloride | 2 | 2002 | 116 | 0.210 |
Why?
|
| Image Enhancement | 7 | 2019 | 2888 | 0.210 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2014 | 1425 | 0.210 |
Why?
|
| Models, Animal | 5 | 2016 | 2115 | 0.200 |
Why?
|
| Elasticity | 3 | 2014 | 655 | 0.200 |
Why?
|
| History, 21st Century | 2 | 2020 | 1567 | 0.200 |
Why?
|
| Muscle Cells | 3 | 2009 | 195 | 0.200 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2001 | 122 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7400 | 0.200 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2164 | 0.200 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 42 | 0.200 |
Why?
|
| Heart, Artificial | 1 | 2022 | 107 | 0.200 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2001 | 69 | 0.190 |
Why?
|
| Arteries | 2 | 2023 | 1121 | 0.190 |
Why?
|
| Intestinal Volvulus | 1 | 2022 | 82 | 0.190 |
Why?
|
| Type C Phospholipases | 1 | 2002 | 286 | 0.190 |
Why?
|
| Oxygen Consumption | 9 | 2005 | 1867 | 0.190 |
Why?
|
| Blood Pressure | 11 | 2023 | 8479 | 0.190 |
Why?
|
| Intensive Care Units | 3 | 2013 | 3744 | 0.190 |
Why?
|
| Indoles | 2 | 2007 | 1830 | 0.190 |
Why?
|
| Disease Progression | 16 | 2022 | 13511 | 0.190 |
Why?
|
| Adenosine Triphosphate | 12 | 2002 | 1988 | 0.190 |
Why?
|
| Phosphatidylinositols | 1 | 2002 | 281 | 0.180 |
Why?
|
| Surgical Instruments | 5 | 2007 | 383 | 0.180 |
Why?
|
| Fetal Diseases | 4 | 2014 | 912 | 0.180 |
Why?
|
| Hematocrit | 5 | 2010 | 623 | 0.180 |
Why?
|
| Bronchiectasis | 1 | 2022 | 139 | 0.180 |
Why?
|
| Vena Cava, Inferior | 5 | 2024 | 459 | 0.180 |
Why?
|
| Algorithms | 11 | 2019 | 14025 | 0.180 |
Why?
|
| Propofol | 1 | 2006 | 602 | 0.180 |
Why?
|
| Predictive Value of Tests | 13 | 2023 | 15308 | 0.180 |
Why?
|
| Isoenzymes | 3 | 2002 | 1682 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 848 | 0.180 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2014 | 951 | 0.180 |
Why?
|
| Atrioventricular Node | 2 | 2020 | 180 | 0.180 |
Why?
|
| Probability | 10 | 2008 | 2478 | 0.180 |
Why?
|
| Cardiovascular Abnormalities | 3 | 2006 | 143 | 0.170 |
Why?
|
| Neuregulin-1 | 1 | 2021 | 135 | 0.170 |
Why?
|
| Lactates | 5 | 1995 | 401 | 0.170 |
Why?
|
| Odds Ratio | 6 | 2016 | 9652 | 0.170 |
Why?
|
| Recurrence | 11 | 2020 | 8457 | 0.170 |
Why?
|
| Elastin | 3 | 2019 | 298 | 0.170 |
Why?
|
| Rats, Wistar | 6 | 2014 | 1848 | 0.170 |
Why?
|
| Pulsatile Flow | 2 | 2011 | 320 | 0.170 |
Why?
|
| Tissue Donors | 4 | 2023 | 2335 | 0.170 |
Why?
|
| Calpain | 1 | 2020 | 146 | 0.170 |
Why?
|
| Analysis of Variance | 9 | 2017 | 6223 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2021 | 1061 | 0.160 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2020 | 58 | 0.160 |
Why?
|
| Renal Artery | 1 | 2021 | 351 | 0.160 |
Why?
|
| Blood Flow Velocity | 6 | 2018 | 1375 | 0.160 |
Why?
|
| Nervous System | 1 | 2002 | 545 | 0.160 |
Why?
|
| Consensus | 3 | 2024 | 3134 | 0.160 |
Why?
|
| Postoperative Period | 8 | 2011 | 1818 | 0.160 |
Why?
|
| Rats, Inbred Lew | 4 | 2016 | 1159 | 0.160 |
Why?
|
| Organ Culture Techniques | 4 | 2013 | 793 | 0.160 |
Why?
|
| Diuretics | 1 | 2002 | 611 | 0.160 |
Why?
|
| Data Display | 3 | 2009 | 174 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 1241 | 0.160 |
Why?
|
| Preoperative Care | 9 | 2014 | 2241 | 0.160 |
Why?
|
| Prospective Studies | 19 | 2024 | 54435 | 0.150 |
Why?
|
| Dogs | 11 | 2004 | 3832 | 0.150 |
Why?
|
| Ligation | 5 | 2013 | 446 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2001 | 407 | 0.150 |
Why?
|
| Fibrosis | 4 | 2020 | 2051 | 0.150 |
Why?
|
| Stem Cells | 5 | 2023 | 3517 | 0.150 |
Why?
|
| Tissue Fixation | 1 | 2019 | 241 | 0.150 |
Why?
|
| Organ Size | 5 | 2014 | 2253 | 0.150 |
Why?
|
| Hydrogels | 1 | 2023 | 720 | 0.150 |
Why?
|
| Developmental Disabilities | 4 | 2008 | 1510 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2015 | 1757 | 0.150 |
Why?
|
| Statistics, Nonparametric | 6 | 2008 | 2854 | 0.150 |
Why?
|
| Blood | 3 | 2014 | 596 | 0.140 |
Why?
|
| Treatment Failure | 5 | 2021 | 2643 | 0.140 |
Why?
|
| Subclavian Artery | 3 | 2007 | 133 | 0.140 |
Why?
|
| Aortic Aneurysm | 2 | 2016 | 648 | 0.140 |
Why?
|
| Disease-Free Survival | 8 | 2015 | 6819 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 5 | 2004 | 287 | 0.140 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 529 | 0.140 |
Why?
|
| Glutaral | 1 | 2017 | 76 | 0.140 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2006 | 1312 | 0.140 |
Why?
|
| Capillaries | 3 | 2010 | 755 | 0.140 |
Why?
|
| Situs Inversus | 2 | 2010 | 63 | 0.140 |
Why?
|
| Calcinosis | 2 | 2017 | 1477 | 0.140 |
Why?
|
| Pediatrics | 1 | 2012 | 3590 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2021 | 749 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2021 | 736 | 0.130 |
Why?
|
| Anisotropy | 2 | 2012 | 1284 | 0.130 |
Why?
|
| Prognosis | 13 | 2023 | 29687 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 1 | 2001 | 869 | 0.130 |
Why?
|
| Pain, Postoperative | 2 | 2024 | 1741 | 0.130 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1999 | 832 | 0.130 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1720 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2014 | 4340 | 0.130 |
Why?
|
| Chronic Disease | 5 | 2013 | 9319 | 0.130 |
Why?
|
| Alanine | 2 | 2001 | 608 | 0.130 |
Why?
|
| Finite Element Analysis | 2 | 2015 | 437 | 0.130 |
Why?
|
| Prostheses and Implants | 5 | 2009 | 1273 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2002 | 808 | 0.130 |
Why?
|
| Ice | 1 | 1996 | 102 | 0.130 |
Why?
|
| Adenosine | 2 | 1997 | 805 | 0.130 |
Why?
|
| Isoantigens | 1 | 2018 | 559 | 0.130 |
Why?
|
| Reproducibility of Results | 15 | 2019 | 20119 | 0.130 |
Why?
|
| Constriction | 3 | 2012 | 168 | 0.120 |
Why?
|
| Angioplasty, Balloon | 2 | 2011 | 589 | 0.120 |
Why?
|
| Aerosols | 1 | 2018 | 635 | 0.120 |
Why?
|
| Organ Preservation Solutions | 1 | 1995 | 100 | 0.120 |
Why?
|
| Aprotinin | 1 | 2015 | 94 | 0.120 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 709 | 0.120 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 11476 | 0.120 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2014 | 25 | 0.120 |
Why?
|
| Rewarming | 1 | 2015 | 64 | 0.120 |
Why?
|
| Life Tables | 5 | 2006 | 364 | 0.120 |
Why?
|
| Computer Systems | 5 | 2011 | 470 | 0.120 |
Why?
|
| Endothelins | 1 | 1995 | 127 | 0.120 |
Why?
|
| Diffusion of Innovation | 2 | 2016 | 730 | 0.120 |
Why?
|
| Assisted Circulation | 1 | 1994 | 100 | 0.120 |
Why?
|
| Morbidity | 3 | 2017 | 1751 | 0.120 |
Why?
|
| Patient Selection | 6 | 2020 | 4246 | 0.120 |
Why?
|
| Stents | 3 | 2012 | 3177 | 0.120 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 95 | 0.120 |
Why?
|
| Aortopulmonary Septal Defect | 2 | 2006 | 7 | 0.120 |
Why?
|
| Oxygen | 6 | 2009 | 4227 | 0.120 |
Why?
|
| Sensitivity and Specificity | 12 | 2011 | 14675 | 0.120 |
Why?
|
| Heart Conduction System | 3 | 2010 | 1008 | 0.110 |
Why?
|
| Phosphorylation | 7 | 2010 | 8300 | 0.110 |
Why?
|
| Surgical Fixation Devices | 1 | 2013 | 8 | 0.110 |
Why?
|
| Defibrillators, Implantable | 2 | 2022 | 1492 | 0.110 |
Why?
|
| Proportional Hazards Models | 12 | 2017 | 12474 | 0.110 |
Why?
|
| Benzophenanthridines | 3 | 2002 | 27 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 794 | 0.110 |
Why?
|
| Phenanthridines | 3 | 2002 | 51 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 1933 | 0.110 |
Why?
|
| Linear Models | 2 | 2014 | 5869 | 0.110 |
Why?
|
| Random Allocation | 3 | 2008 | 2393 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 186 | 0.110 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2005 | 240 | 0.110 |
Why?
|
| Nitroglycerin | 1 | 1995 | 330 | 0.110 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1301 | 0.110 |
Why?
|
| Middle Aged | 22 | 2021 | 220853 | 0.110 |
Why?
|
| Hypothermia | 1 | 2015 | 188 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2005 | 3577 | 0.110 |
Why?
|
| Myocarditis | 3 | 2009 | 792 | 0.110 |
Why?
|
| Bronchial Diseases | 1 | 1994 | 150 | 0.110 |
Why?
|
| Patient Readmission | 2 | 2019 | 3265 | 0.110 |
Why?
|
| Fluoroscopy | 4 | 2013 | 947 | 0.110 |
Why?
|
| History, 19th Century | 1 | 2015 | 718 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2016 | 558 | 0.100 |
Why?
|
| Immunoblotting | 4 | 2006 | 1644 | 0.100 |
Why?
|
| Interleukin-18 | 1 | 2014 | 250 | 0.100 |
Why?
|
| Ventricular Premature Complexes | 1 | 2013 | 112 | 0.100 |
Why?
|
| Magnesium | 2 | 1995 | 804 | 0.100 |
Why?
|
| Massachusetts | 3 | 2017 | 8837 | 0.100 |
Why?
|
| Cohort Studies | 15 | 2019 | 41496 | 0.100 |
Why?
|
| Elastomers | 1 | 2012 | 69 | 0.100 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 172 | 0.100 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1865 | 0.100 |
Why?
|
| Catheters | 1 | 2015 | 426 | 0.100 |
Why?
|
| Insulin | 2 | 2005 | 6588 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5493 | 0.100 |
Why?
|
| Coronary Artery Bypass | 3 | 1999 | 2193 | 0.100 |
Why?
|
| Watchful Waiting | 1 | 2016 | 489 | 0.100 |
Why?
|
| Alkaloids | 3 | 2002 | 191 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2020 | 1050 | 0.100 |
Why?
|
| Models, Biological | 2 | 2008 | 9457 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2010 | 5032 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1141 | 0.100 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2012 | 117 | 0.100 |
Why?
|
| Blood Coagulation Factors | 3 | 2003 | 366 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 1995 | 592 | 0.100 |
Why?
|
| Interleukin-2 | 2 | 1996 | 1891 | 0.100 |
Why?
|
| Pennsylvania | 2 | 2012 | 612 | 0.100 |
Why?
|
| Aorta, Abdominal | 2 | 2013 | 625 | 0.100 |
Why?
|
| Antifibrinolytic Agents | 1 | 2015 | 287 | 0.100 |
Why?
|
| Transplantation, Homologous | 3 | 2018 | 4822 | 0.100 |
Why?
|
| Decision Support Techniques | 2 | 2023 | 2004 | 0.100 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 1115 | 0.100 |
Why?
|
| Body Temperature | 1 | 2015 | 780 | 0.100 |
Why?
|
| Mesoderm | 1 | 2015 | 673 | 0.100 |
Why?
|
| Rats, Zucker | 2 | 2022 | 131 | 0.100 |
Why?
|
| Infarction | 2 | 2023 | 248 | 0.100 |
Why?
|
| Alloys | 1 | 2011 | 110 | 0.090 |
Why?
|
| Amrinone | 2 | 2002 | 14 | 0.090 |
Why?
|
| Deglutition Disorders | 3 | 2007 | 627 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 1 | 2003 | 1923 | 0.090 |
Why?
|
| Echocardiography, Doppler | 5 | 2009 | 898 | 0.090 |
Why?
|
| Dextrocardia | 1 | 2010 | 37 | 0.090 |
Why?
|
| Child Welfare | 3 | 2012 | 521 | 0.090 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2011 | 139 | 0.090 |
Why?
|
| Enzyme Inhibitors | 6 | 2009 | 3702 | 0.090 |
Why?
|
| Atrial Function | 1 | 2011 | 99 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 5662 | 0.090 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 931 | 0.090 |
Why?
|
| Foramen Ovale, Patent | 1 | 2013 | 208 | 0.090 |
Why?
|
| Altitude | 1 | 2011 | 163 | 0.090 |
Why?
|
| Infant Mortality | 2 | 2012 | 752 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2010 | 991 | 0.090 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 3805 | 0.090 |
Why?
|
| Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
| Program Development | 1 | 2016 | 1294 | 0.090 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2009 | 82 | 0.090 |
Why?
|
| Endotoxemia | 3 | 2000 | 196 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1401 | 0.090 |
Why?
|
| Nitric Oxide | 5 | 2005 | 2136 | 0.090 |
Why?
|
| Epithelium | 1 | 2015 | 1603 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 4 | 2012 | 1592 | 0.090 |
Why?
|
| Child Mortality | 1 | 2012 | 199 | 0.090 |
Why?
|
| Cardiomyopathies | 5 | 1996 | 2021 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2010 | 558 | 0.090 |
Why?
|
| Cell Transplantation | 3 | 2006 | 472 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2002 | 213 | 0.080 |
Why?
|
| Heart Function Tests | 2 | 2007 | 318 | 0.080 |
Why?
|
| Heart Rate | 2 | 2012 | 4197 | 0.080 |
Why?
|
| Arteriovenous Fistula | 1 | 2013 | 319 | 0.080 |
Why?
|
| Autoimmune Diseases | 3 | 2009 | 2244 | 0.080 |
Why?
|
| Quality Improvement | 2 | 2016 | 3808 | 0.080 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2009 | 45 | 0.080 |
Why?
|
| STAT4 Transcription Factor | 1 | 2009 | 94 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 3 | 2009 | 2725 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2003 | 3952 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2016 | 1432 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2007 | 1490 | 0.080 |
Why?
|
| Lung | 5 | 2019 | 9979 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 12159 | 0.080 |
Why?
|
| Man-Machine Systems | 1 | 2009 | 42 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 1998 | 1589 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 631 | 0.080 |
Why?
|
| Cost Savings | 1 | 2014 | 911 | 0.080 |
Why?
|
| North America | 1 | 2012 | 1284 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2009 | 196 | 0.080 |
Why?
|
| Plasma Substitutes | 1 | 2008 | 57 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1078 | 0.080 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 454 | 0.080 |
Why?
|
| Bronchitis | 1 | 2009 | 196 | 0.080 |
Why?
|
| Subtraction Technique | 1 | 2011 | 518 | 0.080 |
Why?
|
| Cardiac Myosins | 1 | 2009 | 128 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2021 | 110 | 0.080 |
Why?
|
| Williams Syndrome | 2 | 2001 | 194 | 0.080 |
Why?
|
| Cardiac Volume | 3 | 2003 | 197 | 0.080 |
Why?
|
| Lipopolysaccharides | 6 | 2001 | 2199 | 0.080 |
Why?
|
| Echocardiography, Four-Dimensional | 1 | 2008 | 14 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2020 | 8642 | 0.080 |
Why?
|
| Biological Transport | 3 | 2003 | 2080 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2014 | 947 | 0.080 |
Why?
|
| Infant Welfare | 3 | 2003 | 80 | 0.080 |
Why?
|
| Deoxyglucose | 2 | 2001 | 333 | 0.080 |
Why?
|
| Muscle, Skeletal | 3 | 2009 | 4947 | 0.080 |
Why?
|
| Buffers | 3 | 1995 | 143 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 11856 | 0.070 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 2 | 2009 | 13 | 0.070 |
Why?
|
| Cells, Cultured | 10 | 2021 | 18926 | 0.070 |
Why?
|
| Anastomosis, Surgical | 6 | 2007 | 982 | 0.070 |
Why?
|
| Brachiocephalic Trunk | 1 | 2007 | 40 | 0.070 |
Why?
|
| Transducers | 1 | 2009 | 244 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 1702 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2374 | 0.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1988 | 223 | 0.070 |
Why?
|
| Intraoperative Complications | 3 | 2011 | 1164 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1651 | 0.070 |
Why?
|
| Radiography | 5 | 2012 | 6974 | 0.070 |
Why?
|
| Phosphocreatine | 4 | 2001 | 261 | 0.070 |
Why?
|
| Mice | 13 | 2023 | 81326 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 386 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20588 | 0.070 |
Why?
|
| Organic Chemicals | 2 | 2009 | 210 | 0.070 |
Why?
|
| Deferoxamine | 3 | 1992 | 155 | 0.070 |
Why?
|
| Cause of Death | 6 | 2012 | 3688 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4872 | 0.060 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2005 | 60 | 0.060 |
Why?
|
| Biopsy | 3 | 2013 | 6781 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2005 | 97 | 0.060 |
Why?
|
| Oximetry | 1 | 2009 | 459 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3691 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2007 | 510 | 0.060 |
Why?
|
| Photogrammetry | 1 | 2006 | 77 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 10218 | 0.060 |
Why?
|
| Ischemia | 2 | 2023 | 1889 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 22127 | 0.060 |
Why?
|
| Sorbitol | 1 | 1985 | 57 | 0.060 |
Why?
|
| Remission Induction | 1 | 2011 | 2392 | 0.060 |
Why?
|
| Procaine | 1 | 1985 | 60 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2016 | 2515 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 613 | 0.060 |
Why?
|
| Injections, Intra-Arterial | 2 | 2020 | 181 | 0.060 |
Why?
|
| Signal Transduction | 8 | 2021 | 23416 | 0.060 |
Why?
|
| United States | 8 | 2021 | 72339 | 0.060 |
Why?
|
| Research Design | 2 | 2022 | 6180 | 0.060 |
Why?
|
| Proteomics | 2 | 2022 | 3840 | 0.060 |
Why?
|
| Sex Factors | 3 | 2016 | 10553 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 577 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2008 | 800 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 727 | 0.060 |
Why?
|
| Bundle of His | 1 | 2024 | 101 | 0.060 |
Why?
|
| Surgical Equipment | 1 | 2004 | 57 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11509 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 5 | 2002 | 908 | 0.060 |
Why?
|
| Ventricular Fibrillation | 2 | 2022 | 537 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2006 | 426 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2800 | 0.060 |
Why?
|
| Quinolines | 2 | 2000 | 764 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5842 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 6504 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2002 | 818 | 0.060 |
Why?
|
| Propanolamines | 1 | 2004 | 163 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 1463 | 0.060 |
Why?
|
| Preoperative Period | 2 | 2020 | 551 | 0.060 |
Why?
|
| Reperfusion | 1 | 2005 | 271 | 0.060 |
Why?
|
| Resuscitation | 1 | 2008 | 672 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2005 | 492 | 0.060 |
Why?
|
| Dipeptides | 1 | 2005 | 386 | 0.060 |
Why?
|
| Polypropylenes | 1 | 2023 | 62 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 740 | 0.060 |
Why?
|
| Necrosis | 3 | 2002 | 1610 | 0.060 |
Why?
|
| Vascular Resistance | 4 | 2012 | 933 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 271 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 459 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2016 | 3923 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 808 | 0.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2006 | 265 | 0.050 |
Why?
|
| Truncus Arteriosus | 1 | 2023 | 22 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2003 | 1488 | 0.050 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3551 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2018 | 7966 | 0.050 |
Why?
|
| Cardiography, Impedance | 1 | 2003 | 40 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2010 | 1885 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2006 | 1331 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2006 | 1393 | 0.050 |
Why?
|
| Propranolol | 1 | 2004 | 490 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3031 | 0.050 |
Why?
|
| Prolapse | 1 | 2022 | 63 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 1985 | 574 | 0.050 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 2923 | 0.050 |
Why?
|
| Coronary Angiography | 5 | 2018 | 4506 | 0.050 |
Why?
|
| Connexin 43 | 1 | 2003 | 200 | 0.050 |
Why?
|
| Estrenes | 1 | 2002 | 21 | 0.050 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2003 | 185 | 0.050 |
Why?
|
| Diagnostic Imaging | 4 | 2011 | 3534 | 0.050 |
Why?
|
| Patient Admission | 2 | 2007 | 1365 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2002 | 37 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2008 | 2928 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2010 | 1037 | 0.050 |
Why?
|
| Milrinone | 1 | 2002 | 86 | 0.050 |
Why?
|
| Methods | 2 | 1996 | 1063 | 0.050 |
Why?
|
| Caustics | 1 | 2002 | 32 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2002 | 146 | 0.050 |
Why?
|
| Microcirculation | 2 | 2004 | 1280 | 0.050 |
Why?
|
| Artificial Intelligence | 2 | 2007 | 2576 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 752 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2003 | 230 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2001 | 102 | 0.050 |
Why?
|
| Endotoxins | 2 | 2001 | 520 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1838 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2018 | 696 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4567 | 0.050 |
Why?
|
| Pyrrolidinones | 1 | 2002 | 116 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2004 | 9520 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 2 | 2018 | 249 | 0.050 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2004 | 273 | 0.050 |
Why?
|
| Esophagus | 1 | 2007 | 1036 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 128 | 0.050 |
Why?
|
| Pregnancy | 8 | 2023 | 29893 | 0.050 |
Why?
|
| Maleimides | 1 | 2001 | 112 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 8003 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1600 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 1963 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2008 | 2658 | 0.050 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2000 | 10 | 0.050 |
Why?
|
| Forecasting | 3 | 2006 | 2928 | 0.040 |
Why?
|
| Aging | 4 | 2024 | 8702 | 0.040 |
Why?
|
| Phosphates | 2 | 1995 | 763 | 0.040 |
Why?
|
| Graft Rejection | 4 | 1999 | 4481 | 0.040 |
Why?
|
| Kidney Function Tests | 2 | 2021 | 680 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6505 | 0.040 |
Why?
|
| Free Radicals | 3 | 1989 | 238 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13632 | 0.040 |
Why?
|
| Gestational Age | 4 | 2014 | 3580 | 0.040 |
Why?
|
| Losartan | 1 | 2021 | 263 | 0.040 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 11067 | 0.040 |
Why?
|
| Troponin | 1 | 2023 | 504 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1151 | 0.040 |
Why?
|
| Brain Death | 1 | 2023 | 357 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2021 | 213 | 0.040 |
Why?
|
| Esophageal Stenosis | 1 | 2001 | 197 | 0.040 |
Why?
|
| American Heart Association | 3 | 2008 | 1043 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1880 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 753 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2002 | 341 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6199 | 0.040 |
Why?
|
| Endothelium, Vascular | 3 | 2003 | 4420 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2021 | 276 | 0.040 |
Why?
|
| Thrombophilia | 1 | 2002 | 306 | 0.040 |
Why?
|
| Heparin | 1 | 2006 | 1632 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 143 | 0.040 |
Why?
|
| Tracheal Stenosis | 1 | 2001 | 228 | 0.040 |
Why?
|
| Artifacts | 1 | 2008 | 1912 | 0.040 |
Why?
|
| Exercise Tolerance | 3 | 2016 | 838 | 0.040 |
Why?
|
| Phosphorus Isotopes | 1 | 1998 | 124 | 0.040 |
Why?
|
| Polyesters | 2 | 2011 | 371 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3114 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 1182 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2455 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2011 | 845 | 0.040 |
Why?
|
| Comorbidity | 2 | 2012 | 10516 | 0.040 |
Why?
|
| Digitonin | 1 | 1998 | 25 | 0.040 |
Why?
|
| Metals | 2 | 2013 | 711 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2001 | 1967 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 2636 | 0.040 |
Why?
|
| Superantigens | 1 | 1998 | 126 | 0.040 |
Why?
|
| Mice, Inbred mdx | 2 | 2009 | 88 | 0.040 |
Why?
|
| Calcimycin | 1 | 1998 | 213 | 0.040 |
Why?
|
| Inflammation | 4 | 2014 | 10759 | 0.040 |
Why?
|
| Ionophores | 1 | 1998 | 107 | 0.040 |
Why?
|
| Research | 2 | 2005 | 1976 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2001 | 3770 | 0.040 |
Why?
|
| Potassium Compounds | 1 | 1997 | 42 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2002 | 1756 | 0.040 |
Why?
|
| Bradykinin | 1 | 1998 | 205 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 1999 | 164 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 413 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5103 | 0.040 |
Why?
|
| Lysine | 1 | 2002 | 982 | 0.040 |
Why?
|
| Endocytosis | 2 | 2017 | 950 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4190 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2017 | 201 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 513 | 0.040 |
Why?
|
| Neutrophil Infiltration | 1 | 2019 | 390 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 790 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 181 | 0.030 |
Why?
|
| Serine | 1 | 2001 | 826 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2010 | 546 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15520 | 0.030 |
Why?
|
| Cisplatin | 1 | 2023 | 1652 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2001 | 1226 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2359 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2002 | 816 | 0.030 |
Why?
|
| Body Weight | 1 | 2007 | 4618 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1992 | 1535 | 0.030 |
Why?
|
| Collateral Circulation | 2 | 2003 | 293 | 0.030 |
Why?
|
| Observer Variation | 2 | 2018 | 2610 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2016 | 202 | 0.030 |
Why?
|
| Lysosomes | 2 | 2017 | 921 | 0.030 |
Why?
|
| Raffinose | 1 | 1995 | 53 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 573 | 0.030 |
Why?
|
| Retreatment | 1 | 2017 | 598 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1791 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2019 | 368 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4372 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1999 | 1250 | 0.030 |
Why?
|
| Binding Sites | 2 | 2002 | 5988 | 0.030 |
Why?
|
| Cadaver | 1 | 2020 | 1358 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 2138 | 0.030 |
Why?
|
| Cytokines | 3 | 2019 | 7386 | 0.030 |
Why?
|
| Chemokines | 1 | 2019 | 956 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2002 | 517 | 0.030 |
Why?
|
| Coronary Disease | 5 | 1990 | 5921 | 0.030 |
Why?
|
| Lentivirus | 2 | 2009 | 508 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 900 | 0.030 |
Why?
|
| Manganese | 1 | 1998 | 391 | 0.030 |
Why?
|
| Longevity | 1 | 2022 | 1063 | 0.030 |
Why?
|
| Endosomes | 1 | 2017 | 518 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2003 | 1670 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6312 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 1994 | 82 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1685 | 0.030 |
Why?
|
| Planning Techniques | 1 | 2014 | 82 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1772 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1419 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 387 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1244 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 156 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2022 | 1662 | 0.030 |
Why?
|
| Allopurinol | 1 | 1995 | 198 | 0.030 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2014 | 69 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2009 | 3155 | 0.030 |
Why?
|
| Central Nervous System Diseases | 2 | 2009 | 521 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 1993 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3778 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 1993 | 139 | 0.030 |
Why?
|
| Incidence | 3 | 2008 | 21365 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2024 | 3549 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1999 | 619 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 988 | 0.030 |
Why?
|
| Auscultation | 1 | 2013 | 38 | 0.030 |
Why?
|
| Foreign-Body Reaction | 1 | 2014 | 157 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2015 | 292 | 0.030 |
Why?
|
| Adenine Nucleotides | 2 | 1992 | 110 | 0.030 |
Why?
|
| Pulmonary Surfactants | 1 | 1993 | 162 | 0.030 |
Why?
|
| Glutathione | 1 | 1995 | 581 | 0.030 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2013 | 43 | 0.030 |
Why?
|
| Thrombosis | 2 | 2006 | 2944 | 0.030 |
Why?
|
| Decanoates | 1 | 2012 | 55 | 0.030 |
Why?
|
| Heart Massage | 1 | 1992 | 32 | 0.030 |
Why?
|
| Replantation | 1 | 2014 | 145 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1812 | 0.030 |
Why?
|
| ROC Curve | 2 | 2015 | 3584 | 0.030 |
Why?
|
| Angiostatins | 1 | 2012 | 64 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2014 | 12747 | 0.030 |
Why?
|
| Spleen | 2 | 2009 | 2290 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 2062 | 0.030 |
Why?
|
| Venous Pressure | 1 | 2012 | 55 | 0.030 |
Why?
|
| Bolivia | 1 | 2011 | 23 | 0.020 |
Why?
|
| Respiration, Artificial | 2 | 2015 | 2631 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1995 | 897 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2864 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2012 | 125 | 0.020 |
Why?
|
| Endostatins | 1 | 2012 | 168 | 0.020 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 366 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2011 | 48 | 0.020 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2011 | 27 | 0.020 |
Why?
|
| Sheep | 3 | 1999 | 1436 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2012 | 158 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2006 | 290 | 0.020 |
Why?
|
| Toxoplasmosis | 1 | 1992 | 94 | 0.020 |
Why?
|
| Glycerol | 1 | 2012 | 275 | 0.020 |
Why?
|
| Mass Screening | 1 | 2007 | 5426 | 0.020 |
Why?
|
| Child Development | 1 | 2023 | 2302 | 0.020 |
Why?
|
| Angiography | 2 | 2003 | 1597 | 0.020 |
Why?
|
| Infusions, Intravenous | 3 | 2005 | 2217 | 0.020 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 56 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2012 | 284 | 0.020 |
Why?
|
| Therapeutics | 1 | 2011 | 113 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1636 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2012 | 406 | 0.020 |
Why?
|
| Phosphorus | 1 | 1992 | 332 | 0.020 |
Why?
|
| Argentina | 1 | 2011 | 246 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1995 | 1498 | 0.020 |
Why?
|
| Cell Line | 3 | 2017 | 15545 | 0.020 |
Why?
|
| Myxoma | 1 | 2011 | 114 | 0.020 |
Why?
|
| Intracellular Fluid | 2 | 2001 | 201 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2006 | 4795 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1518 | 0.020 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1991 | 80 | 0.020 |
Why?
|
| Acute Disease | 2 | 2019 | 7226 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2011 | 145 | 0.020 |
Why?
|
| Fura-2 | 1 | 1990 | 107 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2015 | 22174 | 0.020 |
Why?
|
| Shear Strength | 1 | 2011 | 160 | 0.020 |
Why?
|
| Cardiac Output | 2 | 2005 | 831 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2010 | 1017 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 902 | 0.020 |
Why?
|
| Vancomycin | 1 | 1993 | 503 | 0.020 |
Why?
|
| Benzofurans | 1 | 1990 | 139 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2011 | 220 | 0.020 |
Why?
|
| Cell Division | 1 | 1997 | 4451 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 1990 | 211 | 0.020 |
Why?
|
| Homeostasis | 1 | 2001 | 3320 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Diltiazem | 1 | 1990 | 131 | 0.020 |
Why?
|
| Pregnancy Proteins | 1 | 2010 | 223 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2896 | 0.020 |
Why?
|
| Lipid Peroxides | 1 | 1989 | 74 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10756 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 659 | 0.020 |
Why?
|
| Birth Weight | 1 | 2017 | 2104 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 2227 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1994 | 660 | 0.020 |
Why?
|
| Hydrazones | 1 | 2009 | 103 | 0.020 |
Why?
|
| Neuropsychological Tests | 3 | 2008 | 7046 | 0.020 |
Why?
|
| Head | 1 | 2015 | 922 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 730 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1676 | 0.020 |
Why?
|
| Autopsy | 1 | 1992 | 1010 | 0.020 |
Why?
|
| Alprostadil | 1 | 1988 | 86 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 7804 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 12976 | 0.020 |
Why?
|
| NF-kappa B | 3 | 2002 | 2475 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4111 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1997 | 1545 | 0.020 |
Why?
|
| Liver | 1 | 2024 | 7514 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2011 | 577 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 1999 | 826 | 0.020 |
Why?
|
| Aortography | 1 | 1990 | 421 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1987 | 39 | 0.020 |
Why?
|
| Glycogen | 2 | 1986 | 251 | 0.020 |
Why?
|
| Autoantigens | 1 | 2012 | 888 | 0.020 |
Why?
|
| Phantoms, Imaging | 2 | 2007 | 2513 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5300 | 0.020 |
Why?
|
| Disease Management | 2 | 2008 | 2507 | 0.020 |
Why?
|
| Regeneration | 1 | 2017 | 1505 | 0.020 |
Why?
|
| Temperature | 1 | 1994 | 2219 | 0.020 |
Why?
|
| Technology | 1 | 2010 | 294 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 1864 | 0.020 |
Why?
|
| Cell Communication | 2 | 2006 | 1651 | 0.020 |
Why?
|
| Pyridazines | 1 | 2009 | 202 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 169288 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 696 | 0.020 |
Why?
|
| Kidney | 2 | 2021 | 7033 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 4137 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1987 | 294 | 0.020 |
Why?
|
| Ontario | 1 | 2008 | 398 | 0.020 |
Why?
|
| California | 1 | 2011 | 1431 | 0.020 |
Why?
|
| Heart Injuries | 1 | 1989 | 206 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2021 | 12099 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2009 | 961 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 558 | 0.020 |
Why?
|
| Registries | 3 | 2008 | 8247 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1988 | 697 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 629 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 730 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1987 | 158 | 0.020 |
Why?
|
| PAX7 Transcription Factor | 1 | 2006 | 55 | 0.020 |
Why?
|
| Survivors | 2 | 2011 | 2369 | 0.020 |
Why?
|
| Tachycardia | 1 | 1989 | 599 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 823 | 0.020 |
Why?
|
| Desmin | 1 | 2006 | 99 | 0.020 |
Why?
|
| Survival | 1 | 2007 | 161 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1987 | 275 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 16952 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1987 | 427 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 865 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1852 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2006 | 140 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 1240 | 0.020 |
Why?
|
| Hirudins | 1 | 2006 | 179 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2220 | 0.020 |
Why?
|
| Polymers | 1 | 2012 | 1617 | 0.020 |
Why?
|
| Microvessels | 1 | 2009 | 580 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2009 | 1154 | 0.020 |
Why?
|
| Dystrophin | 1 | 2006 | 281 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2010 | 1176 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1831 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1002 | 0.010 |
Why?
|
| Connexins | 1 | 2006 | 352 | 0.010 |
Why?
|
| Surface Properties | 1 | 1987 | 1162 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1986 | 392 | 0.010 |
Why?
|
| DNA Replication | 1 | 2011 | 1415 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3777 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2015 | 4009 | 0.010 |
Why?
|
| Cross-Sectional Studies | 4 | 2006 | 26071 | 0.010 |
Why?
|
| Thrombin | 1 | 2006 | 593 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 942 | 0.010 |
Why?
|
| Pyrazines | 2 | 2000 | 1202 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.010 |
Why?
|
| Cell Separation | 1 | 2009 | 1721 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3596 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2006 | 533 | 0.010 |
Why?
|
| Fetal Death | 1 | 2005 | 435 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5773 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 590 | 0.010 |
Why?
|
| Factor X | 1 | 2003 | 64 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2006 | 366 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2009 | 14392 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3803 | 0.010 |
Why?
|
| Professional Competence | 1 | 2006 | 430 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 143 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2003 | 128 | 0.010 |
Why?
|
| Protein C | 1 | 2003 | 133 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 2003 | 142 | 0.010 |
Why?
|
| Factor VII | 1 | 2003 | 139 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2165 | 0.010 |
Why?
|
| Prothrombin | 1 | 2003 | 192 | 0.010 |
Why?
|
| Iliac Vein | 1 | 1983 | 70 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1132 | 0.010 |
Why?
|
| Factor V | 1 | 2003 | 168 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 825 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2004 | 441 | 0.010 |
Why?
|
| Polyurethanes | 1 | 1983 | 109 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2006 | 702 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1645 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 2003 | 186 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2002 | 203 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2003 | 439 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9616 | 0.010 |
Why?
|
| Gadolinium | 1 | 2007 | 961 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 235 | 0.010 |
Why?
|
| Membranes | 1 | 2001 | 164 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 2000 | 1624 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 318 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17598 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2002 | 294 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2001 | 91 | 0.010 |
Why?
|
| Exercise | 1 | 2018 | 5874 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2001 | 249 | 0.010 |
Why?
|
| Myofibrils | 1 | 2001 | 142 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2009 | 4015 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3885 | 0.010 |
Why?
|
| Abscess | 1 | 2004 | 605 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 1987 | 906 | 0.010 |
Why?
|
| Movement | 1 | 2008 | 1476 | 0.010 |
Why?
|
| Delivery of Health Care | 2 | 2008 | 5333 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2015 | 4384 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2005 | 12341 | 0.010 |
Why?
|
| Sepsis | 1 | 1994 | 2585 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2014 | 2751 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3210 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 2802 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2509 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 802 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2007 | 1267 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 597 | 0.010 |
Why?
|
| Graft Survival | 1 | 1991 | 3843 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2009 | 2307 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1999 | 372 | 0.010 |
Why?
|
| Emergencies | 1 | 2006 | 1217 | 0.010 |
Why?
|
| Boron Compounds | 1 | 2001 | 182 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 2001 | 403 | 0.010 |
Why?
|
| Hemorheology | 1 | 1999 | 144 | 0.010 |
Why?
|
| Dobutamine | 1 | 1999 | 116 | 0.010 |
Why?
|
| Rats, Inbred ACI | 1 | 1998 | 34 | 0.010 |
Why?
|
| Angioplasty | 1 | 2002 | 356 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 488 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2000 | 340 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 2000 | 198 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2000 | 318 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1128 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 3821 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2002 | 911 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 1999 | 203 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5778 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6345 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2008 | 5871 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2561 | 0.010 |
Why?
|
| Vero Cells | 1 | 1998 | 482 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 5311 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4353 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1989 | 3422 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6067 | 0.010 |
Why?
|
| Software | 1 | 2011 | 4431 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1999 | 347 | 0.010 |
Why?
|
| Macrophages | 2 | 2002 | 5753 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1303 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5081 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2000 | 872 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1498 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 1401 | 0.010 |
Why?
|
| Electromyography | 1 | 2000 | 1393 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2004 | 1232 | 0.010 |
Why?
|
| Lasers | 1 | 1999 | 952 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1994 | 108 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4921 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5828 | 0.010 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1993 | 42 | 0.010 |
Why?
|
| Indomethacin | 1 | 1994 | 322 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1998 | 1391 | 0.010 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 149 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1998 | 1243 | 0.010 |
Why?
|
| Antibodies | 1 | 2001 | 2415 | 0.010 |
Why?
|
| Guanidines | 1 | 1994 | 194 | 0.010 |
Why?
|
| Ion Transport | 1 | 1994 | 319 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8519 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 629 | 0.010 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 1992 | 19 | 0.010 |
Why?
|
| Astrocytes | 1 | 2000 | 1340 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 404 | 0.010 |
Why?
|
| Monitoring, Immunologic | 1 | 1991 | 99 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1993 | 970 | 0.010 |
Why?
|
| Hypertension | 2 | 1991 | 8536 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2000 | 2846 | 0.010 |
Why?
|
| Brain | 1 | 1997 | 27092 | 0.010 |
Why?
|
| Vasodilation | 1 | 1994 | 966 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2006 | 3434 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1993 | 1597 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1994 | 839 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 7571 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1998 | 2549 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1993 | 531 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5478 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1998 | 3461 | 0.000 |
Why?
|
| Genome, Human | 1 | 1998 | 4423 | 0.000 |
Why?
|
| Seizures | 1 | 1997 | 2965 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8164 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9566 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1997 | 6242 | 0.000 |
Why?
|
| Neutrophils | 1 | 1993 | 3763 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1998 | 10203 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 944 | 0.000 |
Why?
|
| Mutation | 1 | 2002 | 30002 | 0.000 |
Why?
|